Women's Health
From the Journals
Higher rate of loss seen in unplanned pregnancies for women with epilepsy
Pregnancy planning, maternal age, and interpregnancy interval proved to be significant modifiable risk factors for spontaneous fetal loss.
Conference Coverage
Brexanolone injection quickly improves postpartum depression
BARCELONA – The effects of a single 60-hour infusion lasted at least 30 days.
Conference Coverage
Consider different etiologies in patients with vaginal pruritus
CHICAGO – Vulvar itch is often multifactorial, so clinicians need to chip away at the potential causes.
Conference Coverage
No signal for CV, breast effects with bioidentical vaginal estrogen for dyspareunia
Low-dose vaginal softgel is approved for treating moderate to severe dyspareunia associated with menopause.
Conference Coverage
With more mindfulness, menopausal symptoms wane
Women in midlife with the most stress had the most benefit from mindfulness.
Conference Coverage
Most dermatologic drugs safe for breastfeeding mothers
CHICAGO – Despite many physicians’ concerns, most dermatology drugs do not pose risks to the nursing infant or to...
Conference Coverage
For dyspareunia, intravaginal prasterone may work best soon after menopause
Age and previous hormone replacement therapy did not influence prasterone’s efficacy in treating dyspareunia.
Conference Coverage
Sexual assault and harassment linked to hypertension, depression, and anxiety
Women may lack the financial stability to leave abusive work situations.
Conference Coverage
Breast cancer risk in type 2 diabetes related to adiposity
Women with type 2 diabetes mellitus have a moderately increased risk of breast cancer that appears to be mainly caused by adiposity, not diabetes...
Conference Coverage
Zoledronate reduces fracture risk in elderly women with osteopenia
Women with osteopenia who received intravenous zoledronate had a significantly lower risk of fractures.
From the Journals
No significant VTE risk for women taking noncyclic COCs